The dexamethasone suppression test in the clinical setting
- 1 May 1983
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 140 (5) , 586-589
- https://doi.org/10.1176/ajp.140.5.586
Abstract
The dexamethasone suppression test (DST) was administered to 47 inpatients on a clinical, nonresearch psychiatric unit who were diagnosed according to DSM-III [Diagnostic and Statistical Manual for Mental Disorders-III]. Of the 30 patients with major depression, 23 (77%) exhibited nonsuppression (serum cortisol concentrations > 5 .mu.g/dl); only 1 of the 17 patients with other diagnoses and depressive symptoms exhibited nonsuppression. There was no difference in the rate of nonsuppression between the patients with subgroups of major depression, but those with major depression and psychosis had significantly higher postdexamethasone cortisol levels than those with major depression with and without melancholia and those with diagnoses other than major depression.This publication has 8 references indexed in Scilit:
- Effect of age on DST resultsAmerican Journal of Psychiatry, 1982
- Effect of Age on DST ResultsAmerican Journal of Psychiatry, 1982
- Suicidal Behavior and the DST: Lack of AssociationAmerican Journal of Psychiatry, 1982
- The Dexamethasone Suppression Test for MelancholiaThe British Journal of Psychiatry, 1982
- Clinical Applications of the Dexamethasone Suppression Test for Endogenous DepressionPharmacopsychiatry, 1982
- Cortisol secretion and dexamethasone response in depressionAmerican Journal of Psychiatry, 1981
- A Specific Laboratory Test for the Diagnosis of MelancholiaArchives of General Psychiatry, 1981
- Diagnosis of endogenous depressionJournal of Affective Disorders, 1980